Rationale: 1,049 results found.
|
DIRECT Trial - interferon alfacon-1 plus ribavirin
DIRECT is a randomized, open-label, phase III investigational research study that will evaluate the safety and efficacy of daily administration of subcutaneous interferon alfacon-1 plus ribavirin versus no treatment in HCV patients who have not responded to previous combination therapy with pegylated interferon alfa plus ribavirin.
Directtrial.com ~
Site Info
Whois
Trace Route
RBL Check
|
|
|
|